Cheng, Sheue-yann

Molecular Aspects of Thyroid Hormone Actions

Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews

Thyroid Disorders and TreatmentsEstrogen and related hormone effects

Cited by 1,384

Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy

Sinha, R. A., You, S.-H., Zhou, J., Siddique, M. M., Bay, B.-H., Zhu, X., Privalsky, M. L., Cheng, S.-Y., Stevens, R. D., Summers, S. A., et al. (2012) · Journal of Clinical Investigation

Autophagy in Disease and TherapyThyroid Disorders and Treatments

Cited by 303

In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate

Ashizawa, K., Willingham, M. C., Liang, C. M., & Cheng, S. Y. (1991) · Journal of Biological Chemistry

Metabolism, Diabetes, and CancerCancer, Hypoxia, and Metabolism

Cited by 172

Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature

Flamant, F., Cheng, S.-Y., Hollenberg, A. N., Moeller, L. C., Samarut, J., Wondisford, F. E., Yen, P. M., & Refetoff, S. (2017) · Endocrinology

Thyroid Disorders and TreatmentsEstrogen and related hormone effects

Cited by 165

Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse

Zavacki, A. M., Ying, H., Christoffolete, M. A., Aerts, G., So, E., Harney, J. W., Cheng, S.-Y., Larsen, P. R., & Bianco, A. C. (2005) · Endocrinology

Thyroid Disorders and TreatmentsEstrogen and related hormone effects

Cited by 138

A Thyrotoxic Skeletal Phenotype of Advanced Bone Formation in Mice with Resistance to Thyroid Hormone

O’Shea, P. J., Harvey, C. B., Suzuki, H., Kaneshige, M., Kaneshige, K., Cheng, S.-Y., & Williams, G. R. (2003) · Molecular Endocrinology

Thyroid Disorders and TreatmentsBone Metabolism and Diseases

Cited by 131

Contrasting Skeletal Phenotypes in Mice with an Identical Mutation Targeted to Thyroid Hormone Receptor α1 or β

O’Shea, P. J., Bassett, J. H. D., Sriskantharajah, S., Ying, H., Cheng, S.-Y., & Williams, G. R. (2005) · Molecular Endocrinology

Thyroid Disorders and TreatmentsGrowth Hormone and Insulin-like Growth Factors

Cited by 126

Thyroid Hormones Regulate Fibroblast Growth Factor Receptor Signaling during Chondrogenesis

Barnard, J. C., Williams, A. J., Rabier, B., Chassande, O., Samarut, J., Cheng, S.-Y., Bassett, J. H. D., & Williams, G. R. (2005) · Endocrinology

Osteoarthritis Treatment and MechanismsThyroid Disorders and Treatments

Cited by 85

Characterization of skeletal phenotypes of TRα1PV and TRβPV mutant mice: implications for tissue thyroid status and T3 target gene expression

O'Shea, P. J., Bassett, J. H. D., Cheng, S.-Y., & Williams, G. R. (2006) · Nuclear Receptor Signaling

Thyroid Disorders and TreatmentsBone Metabolism and Diseases

Cited by 53

Thyroid Hormone Receptor α Mutation Causes a Severe and Thyroxine-Resistant Skeletal Dysplasia in Female Mice

Bassett, J. H. D., Boyde, A., Zikmund, T., Evans, H., Croucher, P. I., Zhu, X., Park, J. W., Cheng, S.-Y., & Williams, G. R. (2014) · Endocrinology

Thyroid Disorders and TreatmentsGrowth Hormone and Insulin-like Growth Factors

Cited by 50

Regulation of Fibroblast Growth Factor Receptor-1 (Fgfr1) by Thyroid Hormone: Identification of a Thyroid Hormone Response Element in the Murine Fgfr1 Promoter

O’Shea, P. J., Guigon, C. J., Williams, G. R., & Cheng, S.-Y. (2007) · Endocrinology

Thyroid Disorders and TreatmentsFibroblast Growth Factor Research

Cited by 22